These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6838688)

  • 1. Clinical angiographic regression of atherosclerosis after partial ileal bypass.
    Buchwald H; Moore RB; Rucker RD; Amplatz K; Castaneda WR; Francoz RA; Pasternak RC; Varco RL
    Atherosclerosis; 1983 Jan; 46(1):117-28. PubMed ID: 6838688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Program on the surgical control of the hyperlipidemias: 1994 report.
    Buchwald H; Campos CT
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S3-10. PubMed ID: 8907208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical intervention in atherosclerosis: partial ileal bypass and the Program on Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Fitch L; Varco RL
    Pharmacol Ther; 1985; 29(1):93-109. PubMed ID: 3914647
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Varco RL; Matts JP; Long JM; Fitch LL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    N Engl J Med; 1990 Oct; 323(14):946-55. PubMed ID: 2205799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women in the POSCH trial. Effects of aggressive cholesterol modification in women with coronary heart disease. The POSCH Group. Program on the Surgical Control of the Hyperlipidemias.
    Buchwald H; Campos CT; Matts JP; Fitch LL; Long JM; Varco RL
    Ann Surg; 1992 Oct; 216(4):389-98; discussion 398-400. PubMed ID: 1417188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipoproteins and coronary arteriography in subjects in the program on the surgical control of the hyperlipidemias. Preliminary report.
    Moore RB; Long JM; Matts JP; Amplatz K; Varco RL; Buchwald H
    Atherosclerosis; 1979 Feb; 32(2):101-19. PubMed ID: 222301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Program on the Surgical Control of the Hyperlipidemias: a status report.
    Buchwald H; Moore RB; Matts JP; Long JM; Varco RL; Campbell GS; Pearce MB; Yellin AE; Blankenhorn DH; Holmes WL; Smink RD; Sawin HS
    Surgery; 1982 Oct; 92(4):654-62. PubMed ID: 6750834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is regression of atherosclerosis possible?].
    Thomas D; Richard JL; Emmerich J; Bruckert E; Delahaye F
    Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():47-57. PubMed ID: 1296545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximum lipid reduction by partial ileal bypass: a test of the lipid-atherosclerosis hypothesis.
    Buchwald H; Moore RB; Varco RL
    Lipids; 1977 Jan; 12(1):53-8. PubMed ID: 834123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Program on the Surgical Control of the Hyperlipidemias (POSCH): design and methodology. POSCH Group.
    Buchwald H; Matts JP; Fitch LL; Varco RL; Campbell GS; Pearce M; Yellin A; Smink RD; Sawin HS; Campos CT
    J Clin Epidemiol; 1989; 42(12):1111-27. PubMed ID: 2685177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Campos CT; Boen JR; Nguyen PA; Williams SE
    J Am Coll Cardiol; 1995 Aug; 26(2):351-7. PubMed ID: 7608434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group.
    Buchwald H; Matts JP; Fitch LL; Campos CT; Sanmarco ME; Amplatz K; Castaneda-Zuniga WR; Hunter DW; Pearce MB; Bissett JK
    JAMA; 1992 Sep; 268(11):1429-33. PubMed ID: 1512911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of risk factor management in progression and regression of coronary and femoral artery atherosclerosis.
    Glueck CJ
    Am J Cardiol; 1986 May; 57(14):35G-41G. PubMed ID: 3521250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten years clinical experience with partial ileal bypass in management of the hyperlipidemias.
    Buchwald H; Moore RB; Varco RL
    Ann Surg; 1974 Oct; 180(4):384-92. PubMed ID: 4416064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH Group.
    Matts JP; Buchwald H; Fitch LL; Campos CT; Varco RL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    Control Clin Trials; 1991 Apr; 12(2):314-39. PubMed ID: 1645643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cholesterol reduction on peripheral arterial disease in the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Bourdages HR; Campos CT; Nguyen P; Williams SE; Boen JR
    Surgery; 1996 Oct; 120(4):672-9. PubMed ID: 8862377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of total and low-density lipoprotein cholesterol change after partial ileal bypass.
    Campos CT; Matts JP; Santilli SM; Fitch LL; Long JM; Speech JC; Buchwald H
    Am J Surg; 1988 Jan; 155(1):138-46. PubMed ID: 3341527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-based mortality follow-up from the Program on the Surgical Control of the Hyperlipidemias (POSCH) and meta-analysis of lipid intervention trials. Women in POSCH and other lipid trials.
    Buchwald H; Campos CT; Boen JR; Nguyen P; Williams SE; Lau J; Chalmers TC
    Ann Surg; 1996 Oct; 224(4):486-98; discussion 498-500. PubMed ID: 8857853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarction.
    Matts JP; Buchwald H; Fitch LL; Campos CT; Varco RL; Campbell GS; Pearce MB; Yellin AE; Smink RD; Sawin HS
    J Clin Epidemiol; 1995 Mar; 48(3):389-405. PubMed ID: 7897460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoproteins and the progression/regression of atherosclerosis.
    Barth JD
    Baillieres Clin Endocrinol Metab; 1995 Oct; 9(4):849-66. PubMed ID: 8593128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.